Researchers cut and pasted a series of HIV-resistant genes into T cells, specialized immune cells targeted by the virus.
The detailed changes in the structure of a virus as it infects an E. coli bacterium have been observed for the first time, report researchers from The University of Texas at Austin and The University of Texas Health Science Center at Houston (UT Health) Medical School this week in Science Express.
Discovery of Why Influenza B Virus Exclusively Infects Humans Opens Door for Drugs to Fight Seasonal Epidemics Caused by Virus
The three-dimensional structure of a site on an influenza B virus protein that suppresses human defenses to infection has been determined by researchers at Rutgers University and The University of Texas at Austin.
A conference on biosafety issues in university research will be held May 14 at The University of Texas at Austin.
University of Texas at Austin Pharmacy Researcher Receives $2.6 Million to Develop Vaccine Against Ebola Virus
Dr. Maria Croyle, associate professor of pharmaceutics at The University of Texas at Austin College of Pharmacy, has received $2.6 million to develop a vaccine against Ebola virus infection.